ライフサイエンスコーパス: positivity

1 rebral small vessel disease (CSVD) and Abeta-positivity.

2 vasion were independently associated with LN positivity.

3 blood eosinophilia were associated with PCR positivity.

4 ementia, beyond that attributable to amyloid-positivity.

5 at least 95% sensitivity for predicting T-XM positivity.

6 using variable cutoff percentages to define positivity.

7 LA target does not trigger a twice higher XM positivity.

8 FT4) and thyroid peroxidase antibody (TPOAb) positivity.

9 hairside test and at least one caries lesion positivity.

10 he main outcome measure was frequency of PCR positivity.

11 plantation, and human immunodeficiency virus positivity.

12 95% CI, .06-.82]) were associated with false positivity.

13 se the exact localisation of CD147 and MMP-2 positivity.

14 , and 41.6% of patients had iDSA showing C1q positivity.

15 and negative predictive value (100%) for ISH positivity.

16 nd galactomannan enzyme immunoassay (GM-EIA) positivity.

17 isease-free survival was associated with PCR positivity.

18 fetus with persistent EVD-PCR amniotic fluid positivity.

19 or obesity genetic risk scores and H. pylori positivity.

20 ch from natalizumab due to JC virus antibody positivity.

21 ty or CpG island methylator phenotype (CIMP) positivity.

22 nd by oestrogen and/or progesterone receptor positivity.

23 fection were independent predictors of FoxP3 positivity.

24 ge are strongly associated with future Abeta positivity.

25 odds ratio 6.82, P = 0.0220) of infant HBsAg positivity.

26 , for the time-dependent risk related to ENE positivity.

27 and negative predictive value (99%) for ISH positivity.

28 e the association between patient age and LN positivity.

29 pregulation of cytolytic activity, and PD-L1 positivity.

30 peaking at 250 ms was found - a distraction positivity.

31 erformed to identify high-risk groups for LN positivity.

32 on-HLA autoantibodies in the location of C4d positivity.

33 ts because of retesting prompted by LSG-qPCR positivity.

34 for FT4 1.01, 95% CI 0.91 to 1.12; for TPOAb positivity 1.10, 95% CI 0.83 to 1.46) or after Bonferron

35 y and 25.6% (95% CI: 12.4-38.8%) for EBV DNA positivity; 14.9% (95% CI: 12.4-17.4%) for human herpes

36 stage disease (P < 0.001), but lower margin positivity (20.5% vs 25.9%, P = 0.01) and improved lymph

37 CThad suboptimal accuracy for false positivity: 46% of Xpert-positives with CT> 30 would be

38 was performed using various rates of culture positivity (5 to 50%).

39 Using 1% or higher as the cutoff for ER positivity, 5-year disease-specific survival estimates d

40 djustment was associated with higher culture positivity (6.3 hours in positive vs 4.4 hours in negati

41 Regarding time to positivity, 85% of CPE detected were positive within ten

42 tein-Barr virus (EBV) immunoglobulin M (IgM) positivity, 94.7% (95% CI: 90.7-98.8%) for EBV IgG posit

43 We observed AAA positivity (AAA+) at least 1 time point in 8 of 25 patie

44 des little indication that TSH, FT4 or TPOAb positivity affects IHD, despite potential effects on its

45 rly 2-fold higher odds of persistent culture positivity after 2 months of treatment (adjusted odds ra

46 ients with MCC also exhibited enhanced ABCB5 positivity after carboplatin- and etoposide-based chemot

47 and human epidermal growth factor receptor 2 positivity (all P < 0.0001).

48 error-related negativity, and error-related positivity (all p </= .05).

49 s C for up to 84 days yielded comparable ACT positivities, although there was a drop in signal intens

50 ere further categorized into 3 groups: high (positivity among >40% of monocytes), moderate (positivit

51 oderate (positivity among 10%-40%), and low (positivity among <10%).

52 sitivity among >40% of monocytes), moderate (positivity among 10%-40%), and low (positivity among <10

53 The variation in malaria slide positivity among admissions was examined in logistic reg

54 Positivity among HHCs were as follows: 49% (51 of 104) f

55 sted of prevalence and risk factors of HBsAg positivity among husbands or wives.

56 The rates of DNA positivity among patients were 66.4% (75 of 113) for nas

57 um microscopy (72% vs. 56%) with 80% and 63% positivity among smear-positive and smear-negative confi

58 g the adjusted odds ratio for influenza test positivity among vaccinated compared to unvaccinated par

59 The reward positivity, an event-related potential elicited by feedb

60 Next, we recorded the reward positivity-an electrophysiological signal believed to in

61 vity, 94.7% (95% CI: 90.7-98.8%) for EBV IgG positivity and 25.6% (95% CI: 12.4-38.8%) for EBV DNA po

62 . pylori IgG titer and BMI, nor of H. pylori positivity and BMI.

63 th DSA mean fluorescence intensity, DSA IgG3 positivity and C1q binding capacity adequately reclassif

64 ion with a high prevalence of alpha-gal-sIgE positivity and carry a considerable risk of red meat all

65 ADA positivity and gender were predictors of LOR.

66 The combination of a blunted reward positivity and greater depressive symptom scores at base

67 Heritability estimates for CFA positivity and intensity were 0.23 and 0.18, respectivel

68 ated, with particular focus on the timing of positivity and on the interpretation of combination test

69 excise breast lesions with acceptable margin positivity and re-excision rates.

70 Time-to-positivity and the identity of isolates recovered from e

71 aMMP-8 chairside test positivity and three or more >/=4 mm pockets were associ

72 ly intermittent observation of aerobic plate positivity), and laboratory factors (novel equipment).

73 ocality, extrahepatic extension, grade, node positivity, and age greater than 60 years are independen

74 y endpoints included overall survival, HBsAg positivity, and changes in liver biochemistry and antibo

75 risk factors, joint pain, rheumatoid factor positivity, and inflammatory markers (white blood cell c

76 atypia, P53 abnormality, and Aurora kinase A positivity, and the interaction of age, waist-to-hip rat

77 of instrumental coping, good social support, positivity, and use of assistive aids.

78 HBV antibodies and GM-EIA positivity are common in patients receiving IVIG and con

79 Here, 102 patients with GFAP-IgG positivity are described.

80 The value of AR positivity as a prognostic marker has not yet been defin

81 of 80% (95% CI, 74 to 84) to predict culture positivity at 2 months with a high negative predictive v

82 ng from natalizumab due to JC virus antibody positivity at 3 Swedish multiple sclerosis centers with

83 A blunted reward positivity at baseline predicted first-onset depressive

84 Patients with CMV IgG positivity at baseline were more likely to develop a sev

85 pithelialization rates stratified by culture positivity at day 6.

86 ited a nonsignificant trend toward increased positivity at prolonged incubation times.

87 Referred to as "linguistic positivity bias" (LPB), this effect has been found acros

88 urgh compound-B positron emission tomography positivity, but the ability of these thresholds to detec

89 ty included a minimum requirement of FRalpha positivity by immunohistochemistry (>/= 25% of tumor cel

90 tomated filter-based wash step reduces false positivity by removing residual DNA associated with noni

91 We determined prevalence estimates of test positivity, calculated test agreement and kappa statisti

92 group and the same group revealed more BMP-2 positivity compared with other groups.

93 Gametocyte density and positivity correlated closely with parasitemia, and popu

94 n the form of the broad-band centro-parietal positivity (CPP) and limb-selective beta-band (8-16 and

95 plications, circumferential resection margin positivity (CRM+) and other pathological outcomes, quali

96 ly associated with poor outcome (CSF culture positivity, CSF white blood cell count, hemoglobin, Glas

97 assays, scoring systems, and thresholds for positivity currently used.

98 The time to UTI with culture positivity did not differ significantly between groups (

99 a logistic regression analysis, baseline aPL positivity did not increase the odds of brain infarcts (

100 Although PD-L1 positivity enriches for populations with clinical benefi

101 ype 1 diabetes (T1D) defined by autoantibody positivity, establishing evidence for differential genet

102 henotypes: CD1a(-), CD8(-), CD5(-)(dim), and positivity for 1 or more stem cell or myeloid antigens.

103 We defined IA as positivity for at least one autoantibody (GADA, IAA, or

104 D30, together with absent (79%) or low (21%) positivity for CD25, CD2, or both.

105 Immunohistochemistry revealed positivity for cluster of differentiation (or CD) marker

106 These perinuclear vesicles displayed positivity for histone interacting protein, heterochroma

107 detection of endomysium antibodies (EMA) and positivity for HLA-DQ2/DQ8.

108 valuate the predictors of persistent culture-positivity for MAC (MAC-PP) and its impact on radiograph

109 ly in a subgroup of children identifiable by positivity for multiple autoantibodies.

110 Immunohistochemical positivity for p4E-BP1 or insulin-like growth factor-1 r

111 Linear mixed modelling showed that only positivity for parasitic infections was a significant pr

112 bial-loaded cement on sonicate fluid culture positivity for the diagnosis of prosthetic joint infecti

113 (exercise), and Sox2(+) precursors acquired positivity for the neuronal marker NeuN over time and in

114 red with genotype-negative (TT) non-smokers, positivity for the risk genotypes (CC+CT) alone and curr

115 e for differential genetic architecture with positivity for thyroid-peroxidase-specific antibody, dri

116 Positivity for viruses other than influenza virus was no

117 ror processing (error-related negativity and positivity) from an arrow flanker task with low-conflict

118 ences; however, the latter exhibited earlier positivity, greater selectivity, and more intense indica

119 ongly associated with estrogen receptor (ER) positivity (GRPR was high in 83.2% of ER-positive and 12

120 of human epidermal growth factor receptor 2 positivity (>/= 1+ by immunohistochemistry) in his nephr

121 Screening participation, FIT positivity (>/=20 microg of hemoglobin/g), positive pred

122 The cumulative ADA positivity (>10 ng/mL) and low TL (<5.0 mug/mL) was 12.1

123 bility estimates were high for microfilarial positivity (h(2) = 0.74) and microfilarial density trait

124 her patient with anti-NMDA receptor antibody positivity had evidence of an ovarian teratoma.

125 Patients with persistent ymrEMVI-positivity had significantly worse DFS at 3 years (42.7%

126 ces at the cumulative incidence of anti-TG2A positivity (hazard ratio, 1.14; 95% confidence interval,

127 eficiency virus, hepatitis B surface antigen positivity, hepatocellular carcinoma, or missing HCV RNA

128 lness characterized by anti-EBV IgM antibody positivity, high loads of circulating latently infected

129 isease-free survival was associated with IHC positivity; however, patients who had IHC-positive N2 LN

130 10 decrease; 95% CI, 1.04-1.30), CSF culture positivity (HR, 1.37; 95% CI, 1.02-1.84), and blood neut

131 investigate the prevalence of alpha-gal-sIgE positivity in a population of forest service employees w

132 istry showed patches of ribosomal protein S6 positivity in a similar distribution.

133 RV positivity in BAL fluid was a predictor for allo-LSs (ha

134 Observations: The rate of AR positivity in breast cancer is about 60% to 80%.

135 that reduces Pseudomonas aeruginosa culture positivity in CF patients with unclear mechanisms.

136 Primary outcome of interest comprised HBsAg positivity in couples (both positive: F+M+, only wife po

137 Positivity in either assay prompted thoracic computed to

138 Thus, t(11;14) positivity in HDM-treated AL patients conferred superior

139 1.46) were significantly predictors of HBsAg positivity in husbands.

140 ncer associations differed by hepatitis sera-positivity in nested analyses for a subset of cases (n =

141 damage response, manifesting as gamma-H2A.X positivity in neurons of the spinal cord and brain.

142 3.8; 95% CI, 1.4-10.7; P = .01), whereas RV positivity in NPAs only was not.

143 The identification of anti-HBc positivity in the absence of HBsAg in organ transplant d

144 The prevalence of alpha-gal-sIgE positivity in the current and historic cohort was compar

145 ated aspartate aminotransferase (AST) level, positivity in the nonstructural protein 1 (NS1) rapid te

146 or negativity and a later (>300 ms) parietal positivity in the time domain and an increase in low-fre

147 after blinatumomab therapy and show BCR-ABL1 positivity in their hematopoietic stem cell (HSC)/progen

148 an important factor in estimating lymph node positivity in thin melanoma independent of traditional p

149 Prevalence and predictors of HBsAg positivity in wives had similar results.

150 Osteocalcin positivity in XG groups was higher than in control group

151 Combined cMRI and OCB positivity indicated a 26.84-fold higher HR for developi

152 enetic predisposition to RA, such as HLA-DR4 positivity, indicates that dendritic cells (DC) are of c

153 cies without antiviral prophylaxis, anti-HBs positivity is associated with a decreased risk of reacti

154 her tissue sites, this interpretation of p16 positivity is not applicable to periocular SC.

155 ity of the epithelioid cells, and the HMB-45 positivity is often weaker or absent in spindle cells.

156 del using 10% or higher as the cutoff for ER positivity, it was 3333.38, indicating that the model fi

157 no differences in lymph node harvest, margin positivity, length of stay, readmission rate, 30-day mor

158 Predictors of future Abeta positivity (levels of CSF Abeta42 declining below a prev

159 ell carcinoma of the anus (SCCA), lymph node positivity (LNP) indicates poor prognosis for survival a

160 PD-L1 positivity may be a result of genetic events leading to

161 Strong immunohistochemical p16 positivity (meeting the criterion of >70% nuclear and cy

162 The relationship between DELC and Abeta-positivity might be explained by the causative role of C

163 Node positivity negatively impacted DFS (p = 0.04).

164 and tubular epithelial cells, with a median positivity of 20% and 40%, respectively.

165 ing to its infrequency and/or a delay in the positivity of a cerebrospinal fluid (CSF) culture or CSF

166 ed to characterize the distribution of nodal positivity of adult patients diagnosed with localized >/

167 Molecular recurrence (MR) was defined as positivity of BCR-ABL transcript in a quantitative rever

168 Antibiotic use did not affect the rate of positivity of FUBC, unless bacteria were not sensitive t

169 ction in rural couples, and partner's double positivity of HBeAg and HBsAg was the most significant f

170 HBV-DNA positivity was determined by positivity of nested polymerase chain reaction in at lea

171 y increased risk of prostate cancer with the positivity of overall HPV detected in prostate tissues (

172 We estimated the frequency and positivity of pharyngeal or urine specimens tested for G

173 CT on the index date, and the frequency and positivity of repeat rectal testing or any follow-up tes

174 OR = 2.61), HBeAg(-)/HBsAg (+) (AOR = 2.23), positivity of syphilis (AOR = 1.50), living in a high-ri

175 large US commercial laboratory, we estimated positivity of the first rectal GC and CT test ("index" t

176 men who declined to enroll, but the HIV test positivity of the two groups was similar (1.9% vs. 2.0%;

177 Early BKV positivity of urine and blood indicates later BKV nephro

178 nverted from single to multiple autoantibody positivity on follow-up.

179 anti-PD-1-treated melanoma patients, MHC-II positivity on tumour cells is associated with therapeuti

180 Addition of DSA IgG3 positivity or C1q binding capacity increased discriminat

181 Both patients with either HBsAg positivity or viremia had recurrent hepatocellular carci

182 adiation dose had a similar resection margin positivity (OR, 0.99; 95% CI, 0.72-1.35; P = .92), perma

183 B surface antigen, or anti-hepatitis C virus positivity (OR, 5.38; 95% CI: 1.60-18.0; P = 0.006), and

184 ulations with either confirmed blood-culture positivity, or blood-culture negativity.

185 R2-negative) tumors, lymphovascular invasion positivity, or estimated distant relapse risk of greater

186 Correlation of the KRAS-variant, p16 positivity, outcome, and TGF-beta1 levels was evaluated.

187 V positive, with no significant trend in HIV positivity over time.

188 itivity was significantly greater than false positivity (P < 0.0001).

189 gher levels of CRP were associated with ASST positivity (P = .009) and arterial hypertension (P = .00

190 .05), higher levels of apoptosis (Annexin V positivity, P < .005), and less lung allergic inflammati

191 der: p < 0.001, OR:7.8 CI 95%: 2.5-24.3, ADA positivity: p = 0.007 OR:3.6 CI 95%: 1.4-9.5).

192 to report the prevalence of TB-blood-culture positivity, performance of rapid diagnostics as diagnost

193 ethods were used to compare resection margin positivity, permanent colostomy rate, 30-day readmission

194 e and oncologic outcomes encompassing margin positivity, permanent ostomy rate, postoperative readmis

195 ntaged neighborhoods exposed to low maternal positivity predicted increased rates of school noncomple

196 The authors examined whether the reward positivity prospectively predicted the development of de

197 reaction time variability, and error-related positivity (r = .19-.23, p </= .05).

198 The FIT positivity rate (5.0%) and positive predictive values (a

199 Per test positivity rate (p = 0.008) and incidence (p < 0.001) we

200 Temporal changes in the malaria test positivity rate (TPR) were estimated during and after IR

201 -based surveillance to estimate malaria test positivity rate (TPR), expressed as the number testing p

202 young MSM, HIV prevalence was 5.5%, per test positivity rate 3.6%, and HIV incidence 3.4 per 100 pers

203 PAF but in only 49% of samples with a higher positivity rate at the proximal site in IPD.

204 t, no significant difference was seen in the positivity rate between prodromal Parkinson disease pati

205 The malaria parasite positivity rate by RDT and microscopy among children wit

206 The rotavirus positivity rate declined from 40.1% (449/1121) in prevac

207 Culture positivity rate for the multi-sample method and ESwab wa

208 favorable effect on patient outcomes, margin positivity rate has not changed significantly over the y

209 survival than those treated at expected SLNB positivity rate hospitals (90.0% vs 91.9%, P = 0.014; ha

210 patients treated at lower-than-expected SLNB positivity rate hospitals had worse 5-year survival than

211 The positivity rate in 626 HCWs with no identifiable risk fa

212 ion was noted in infants, with the rotavirus positivity rate in this age group declining from 40.9% i

213 A hospital's SLNB positivity rate may reflect its SLNB proficiency for mel

214 tion of a QFT-Plus-positive result yielded a positivity rate of 1.0% (CI, 0.2 to 1.7; P value of 0.00

215 atients had nodal metastases, for an overall positivity rate of 3.8% (95% CI, 3.4%-4.2%).

216 rally not be recommended for SLNB, had an LN positivity rate of 5.6% (95% CI, 3.3%-8.6%); conversely,

217 rospective study was performed assessing the positivity rate of MRI versus (18)F-FDG PET/CT during th

218 generally be recommended for SLNB, had an LN positivity rate of only 3.9% (95% CI, 2.7%-5.3%).

219 The Bacillus positivity rate of YTC samples was 72.7%; Bacillus was n

220 reast cancer did not affect the overall HER2-positivity rate or the proportion of patients eligible f

221 The false-positivity rate was 27% in U.S. states, 18% in the USVI,

222 2009 showed statistically significant lower positivity rates (0.6%).

223 30.1%-35.2%, respectively) and almost equal positivity rates (2.8%-3.4%, 5.8%-6.1%, and 10.1%-10.9%,

224 n-expected sentinel lymph node biopsy (SLNB) positivity rates and whether hospitals with lower- or hi

225 (1,990 total women) for CT and GC only, with positivity rates for CT, GC, and TV of 7.1%, 2.3%, and 1

226 According to the reference method, the positivity rates for MRSA in the population evaluated we

227 rvival differences were not observed by SLNB positivity rates for stage II/III.

228 Positivity rates for the galactomannan assay in serum an

229 The positivity rates for volume-compliant bottle pairs deter

230 als with lower- or higher-than-expected SLNB positivity rates have worse patient outcomes.

231 Hospital SLNB positivity rates may be a novel measure to confidentiall

232 respectively, compared to conventional qPCR positivity rates of 0%, 0%, 30%, and 100% and CFU detect

233 0) for Universal 16S rRNA gene targets, with positivity rates of 9.4% (105/1,120) and 11.3% (126/1,12

234 ese challenges can be addressed by adjusting positivity rates to account for poor sensitivity or inco

235 Adjusted hospital SLNB positivity rates varied widely.

236 y at hospitals with lower-than-expected SLNB positivity rates was associated with decreased survival.

237 Hospital-level SLNB positivity rates were adjusted for patient- and tumor fa

238 and higher-than-expected (high tercile) SLNB positivity rates were more likely to be low-volume hospi

239 est 30- and 90-day mortality, highest margin positivity rates, and lowest lymph node counts.

240 Success rates, node positivity rates, and rates of regional recurrence after

241 ionality of laboratory and response systems, positivity rates, and the geographic distribution of spe

242 ntended levels of specificity and manageable positivity rates.

243 ds to yield defined levels of specificity or positivity rates.

244 were divided into terciles of adjusted SLNB positivity rates.

245 8 patient cases; 2,278 v 2,659 tumors), HER2 positivity remained constant (15.7% v 15.5%, respectivel

246 greater than 0.7 IU/ml, tuberculin skin test positivity results were 15%, 53%, 66%, and 91% (P < 0.00

247 rrelation of keratitic precipitates with PCR positivity, RESULTS: The overall PCR positivity was 48.9

248 cs included are age at multiple autoantibody positivity, sex, selected high-risk HLA-DR-DQ genotypes,

249 With a positivity threshold of 39 cycles, the sensitivity and s

250 antigen flow bead MFI thresholds allowing XM positivity to be predicted were calculated with receiver

251 tained smokers exhibited a heightened reward positivity to cigarette rewards relative to monetary rew

252 ng units per milliliter (CFU/mL) and time to positivity (TTP).

253 ures such as visual acuity, baseline culture positivity, type of filamentous fungal organism and dura

254 e of alpha-gal-specific IgE (alpha-gal-sIgE) positivity varies between different populations from div

255 Among IHC 2+ patients, HER2 FISH positivity was 11.8% (FDA), 9.4% (AC2007), and 24.1% (AC

256 Overall anorectal chlamydia/gonorrhea positivity was 13.4% (n = 127)/1.3% (n = 12).

257 The overall B. pertussis PCR positivity was 2.3% (42/1839), of which 86% (n = 36) occ

258 d hunters, the odds ratio for alpha-gal-sIgE positivity was 2.48 compared to the residential populati

259 Repeat culture positivity was 31% (92/299).

260 ith PCR positivity, RESULTS: The overall PCR positivity was 48.9 % (22/45).

261 P16 positivity was a good surrogate for ISH+ tumor status am

262 These results show that pre-HCT BAL fluid RV positivity was a predictor for allo-LSs.

263 The reward positivity was also a significant predictor independent

264 lycemia, and decline in insulin autoantibody positivity was an immune biomarker of therapeutic outcom

265 ACA-positivity was associated with old age and was observed

266 False positivity was associated with recent previous tuberculo

267 Influenza virus positivity was associated with shorter duration of hospi

268 Alpha-gal-sIgE positivity was associated with total IgE levels and rece

269 Positivity was at least 5.7% in rectal GC, rectal CT, or

270 PD-L1 positivity was defined as >/=5% of cells based on immuno

271 Amyloid-positivity was defined as 11C-Pittsburgh compound B targ

272 PD-L1 positivity was defined as expression by immunohistochemi

273 PD-L1 positivity was defined as expression in 1% or more of tu

274 Neither nasal passage nor mucosa positivity was determinant of later disease onset; howev

275 HBV-DNA positivity was determined by positivity of nested polyme

276 Rare GFAP-IgG positivity was encountered in serum controls by tissue-b

277 Blood pneumococcal PCR positivity was higher in children from the 5 African cou

278 PET4 positivity was higher with R-CHOP14 vs R-ACVBP (54% vs 4

279 At baseline, the adolescents' reward positivity was measured using a monetary guessing task,

280 III at enrollment, interferon gamma ELISPOT positivity was more common in those in whom colonization

281 False-positivity was more likely during the second year and wa

282 Phosphorylated alpha-synuclein positivity was seen in 22 of 39 (56%) prodromal Parkinso

283 CD14 positivity was seen in both FP-MSCs and SF-MSCs, and was

284 For all samples, PCR positivity was significantly associated with cases of IA

285 In the clinical study, true positivity was significantly greater than false positivi

286 H13 positivity was significantly lower than that of HC2 amon

287 Error positivity was similar in 1PP and 3PP, suggesting that c

288 itive samples (n = 252), the time to culture positivity was used to estimate bacillary load.

289 iratory virus infection, and Aspergillus PCR positivity were all significant risk factors for develop

290 Female gender and ADA positivity were associated with LOR (female gender: p <

291 Clinicopathologic factors associated with LN positivity were characterized, using logistic regression

292 tions between chemical concentration and ANA positivity were observed, but only the association in ma

293 ations (<350 mg/dL) and insulin autoantibody positivity were predictors of the stable reversal of hyp

294 re, genotype C infection, and maternal HBsAg positivity were significantly associated with delayed HB

295 nadequate lymph node staging (LNS) and nodal positivity were strong predictors of risk-adjusted morta

296 al performance and clinical utility (time to positivity) were calculated for both kinds of samples.

297 ion exhibiting an intermediate level of CD41 positivity while maintaining its expression of CD34.

298 Final HER2 positivity with AC2013 (23.6%) was increased (P < .001)

299 ositive at </=8 years, indicating no loss of positivity with chronicity.

300 aused an increase in prevalence, reduced RDT positivity within symptomatic patients but no change in